Investing.com — Incannex Healthcare Inc. (NASDAQ: IXHL) stock jumped 10% Friday following the release of positive Phase 2 trial results for its obstructive sleep apnea (OSA) treatment, IHL-42X.
Incannex stock surges after positive sleep apnea trial results
view original post